Researchers in Japan have long looked to the sea for sources of new medications. A big focus has been on astaxanthin found in microalgae.1,2
Astaxanthin functions as a natural sunscreen for marine plants.3 Because astaxanthin is so effective at absorbing solar radiation, investigators first proposed it would make an effective topical sunscreen.1-4 But as researchers looked closer, they discovered that astaxanthin shields other areas against destructive free radicals.4,5
Almost every cell in the body, including the eyes, brain, heart, and kidney, can benefit from astaxanthin.1,6,7 Recent laboratory studies show that astaxanthin can even increase life span!8,9
The discovery of a new way to boost astaxanthin absorption by 12-fold means more of this broad-spectrum nutrient is available to your entire body.
Astaxanthin is a red pigment molecule that is a member of the carotenoid family found in certain marine algae. When eaten by shrimp and crustaceans, the pigment lends its reddish hue to their shells.10 As astaxanthin makes its way up the food chain, the color becomes still more concentrated, creating the beautiful reds and pinks we see in fish such as salmon and in marine birds like flamingos.6,10
Researchers have sought to explore the use of astaxanthin as a topical sunscreen because of its powerful ultraviolet light-absorbing properties.5 They soon found, however, that astaxanthin has many additional benefits, including free radical scavenging, mitochondrial protection, anti-inflammatory effects, and protection from glycation.11-18
In the words of one researcher, astaxanthin shows “demonstrable promise for slowing age-related functional decline.”19
Though the work is only in its infancy, astaxanthin has already been shown to extend the life span of the simple worm called C. elegans.8,9 Extending life in primitive organisms like C. elegans is an important first test of compounds with the potential for increasing longevity in humans.
Let’s examine some of the more compelling literature on astaxanthin, highlighting its vast ability to protect and promote healthy immune functioning, reduce cancer risk, mitigate the impact of diabesity, protect heart muscle and blood vessels, slow brain aging, and support eye health.
Astaxanthin: Potent Skin Protection from the Inside Out
Recent studies show that astaxanthin can rejuvenative skin from within.4,11,20 Astaxanthin is among the most powerful and versatile marine plant antioxidants known, and as such, it has the ability to scavenge skin-damaging free radicals.4,19,21 Even though astaxanthin is widely distributed through most organs in the body, it accumulates in the skin, where it makes its way into all skin layers (topical sunscreens can reach only the outermost layers).22,23 This can provide potent protection against ultraviolet radiation, the most powerful environmental risk factor for skin cancer.4
Skin cells that are exposed to ultraviolet light produce bursts of free radicals that trigger aging effects such as skin sagging and wrinkles, and promotes cancer.4,24 When astaxanthin is applied to skin cells in culture, it prevents all of those ultraviolet-induced destructive effects, suggesting that it should significantly prevent ultraviolet-induced skin aging.4,24,25
Human studies demonstrate that 6 mg/day of astaxanthin for 6-8 weeks reduces crow’s feet wrinkles, water loss, and age spot size while enhancing moisture content, elasticity, and skin texture in both men and women, particularly when combined with topical astaxanthin application.23
Boosting Immune Function
Your immune system protects you from infections and routinely patrols your body for emerging cancer cells, but when it is over-activated, it can trigger allergic responses such as asthma and autoimmune diseases. Studies demonstrate that astaxanthin helps balance the immune system by stimulating its infection- and cancer-fighting components—while also helping suppress the overactive immune responses that create needless inflammation.26
Astaxanthin increases the numbers and activity of white blood cells called lymphocytes and natural killer cells that are responsible for creating the body’s innate immune response to invaders.27-29 In a mouse model of breast cancer, astaxanthin-treated animals showed higher levels of cancer-killing cells and protective interferon, resulting in delayed tumor growth.27
Astaxanthin has similar immune-boosting effects in humans, improving the ability of protective white blood cells to surround and destroy infecting organisms, especially fungi such as Candida albicans.30 Astaxanthin also protects human lymphocytes and neutrophils against the oxidant stresses imposed by the actions of certain white blood cells without reducing the killing effects of white blood cells themselves.30,31
Human studies reveal astaxanthin’s beneficial actions on the over-activated immune system in patients with allergies and asthma. When astaxanthin (along with ginkgo extract) was applied to white blood cells from asthmatic patients, it suppressed reactive cell activation as well as or better than the antihistamine drugs cetirizine (Zyrtec®) and azelastin (Astelin®).32 A subsequent study showed that combining these compounds with the drugs resulted in improved antihistamine activity.33
Preventing Cancer at Every Stage
Epidemiological studies reveal that dietary intake of astaxanthin along with other carotenoids is associated with the reduced risk of many different types of cancer. Increased intake of carotenoids such as astaxanthin typically lowers cancer risk.34
Unlike many pharmaceuticals, astaxanthin shows beneficial effects against cancer at each stage of its development.
- It prevents cancer initiation by protecting DNA from ultraviolet and oxidant damage.4,35
- It promotes early detection and destruction of cells that have undergone malignant transformation by boosting immune surveillance.7
- It prevents cancerous growth in cells that evade immune detection by reducing inflammatory changes such as those that appear in aging.12,36
- It blocks the rapid cell replication of tumors in their growth phase by stopping the cancer cell reproductive cycle and restoring cancer cells’ ability to die off by apoptosis.37-40
- It prevents tumors from spreading by reducing tumor production of tissue-melting proteins.36
Animal studies show that these properties of astaxanthin contribute to a reduced number of precancerous lesions in the colon, and to fewer and smaller tumors when they do develop in the colon and breast.27,41
Reducing Diabesity and Its Consequences
Diabetes and obesity are so closely intertwined that scientists now speak of them together as one entity, diabesity. Diabesity is a major component of metabolic syndrome. Astaxanthin holds multiple benefits in managing diabesity, with its resulting oxidant stress, high levels of chronic inflammation, and extensive tissue damage from protein and lipid glycation.42
Lab studies reveal that when obese and/or diabetic animals are supplemented with astaxanthin, they experience lower blood glucose levels, improved insulin sensitivity, and reduced inflammation and oxidative stress.42-45 In addition, astaxanthin preserved the ability of the pancreas to secrete insulin.42
Astaxanthin supplementation also prevents massive body weight gain in animals fed high-fat or high-fructose diets.45,46 Obese animals, like obese humans, develop dangerous fat accumulations in their livers, predisposing them to cirrhosis and liver cancer. Astaxanthin supplements have been found to reduce liver fats and triglyceride levels.46 In overweight and obese humans, astaxanthin suppresses dangerous lipid peroxidation and stimulates healthy natural antioxidant defenses in the body.47
In addition to preventing the main elements of diabesity, astaxanthin helps alleviate the long-term consequences faced by diabetics. Studies show that astaxanthin supplementation slows the development of diabetic nephropathy (kidney disease),43,48 reduces cataract formation and diabetic retinopathy (both preventable forms of blindness in diabetics),49,50 and reduces the many cardiovascular complications of diabesity.51
Protecting Cardiovascular Health
Astaxanthin has powerful antioxidant effects that fight cardiovascular diseases at multiple levels. In hypertensive rats, astaxanthin lowers blood pressure, improves endothelial function, and delays hyper-tension-induced strokes.52-54 In humans and animals, astaxanthin helps normalize lipid profiles, reducing triglyceride and cholesterol levels while boosting beneficial HDL-cholesterol.55,56 These effects reduce the risk of a clot forming within a major vessel.
Astaxanthin also reduces inflammation and reduces the production of certain enzymes that destabilize plaques and make them vulnerable to rupture and that block blood flow.57
In the heart muscle itself, astaxanthin boosts mitochondrial energy delivery, which helps the heart muscle contract more powerfully and efficiently.58 This is especially valuable in the event of a heart attack because it helps surviving muscle to rapidly take over from damaged areas.
People with cardiovascular disease are at risk for vascular dementia, a form of cognitive decline caused by decreased brain blood flow and damage to cerebral vessels. Astaxanthin supplements in such animals reduce the rate of complications such as strokes, and improve cognitive performance, allowing the animals to live more vigorous and active lives.52
Slowing Brain Aging
Astaxanthin exerts multiple beneficial effects in the brain.59 Unlike many other antioxidant molecules, astaxanthin crosses the blood-brain barrier, allowing it to saturate and protect brain tissue.14 These features have led experts to label astaxanthin a “natural brain food.”14
In animal models, astaxanthin has been found to reduce the risk of stroke, diminish the size of stroke areas in the brain, and improve motor activity following a stroke.60-62 One study, in fact, demonstrated that pre-treatment with astaxanthin completely prevented ischemic brain injury following 2 hours of blockage of one of the brain’s largest arteries.62
Astaxanthin also directly combats the oxidative impact of abnormal proteins in both Alzheimer’s and Parkinson’s diseases.59,63,64 Studies show that beta-amyloid, the toxic protein found in the brains of Alzheimer’s patients, is also found on red blood cells, where it reduces oxygen delivery to tissues.65 Supplementation with astaxanthin has been found to decrease the accumulation of amyloid-beta on red blood cells.66
A human study has determined that doses of astaxanthin as high as 20 mg once daily for 4 weeks are free of side effects and suggested that the supplement was effective for age-related decline in cognitive and psychomotor functions.67 And 12 mg/day astaxanthin improved cognitive health scores and learning scores in a study of healthy middle-aged and elderly subjects with age-related forgetfulness.68
Important Promoter of Eye Health
Age- and diabetes-related eye diseases contribute to visual impairments and blindness in millions of Americans. Astaxanthin has been found to prevent or slow three of the most common eye diseases: age-related macular degeneration, cataracts, and glaucoma.
The human retina naturally contains the carotenoids lutein and zeaxanthin, molecules closely related to astaxanthin. Supplementation with all three carotenoids (astaxanthin 4 mg/day, lutein 10 mg/day, zeaxanthin 1 mg/day) has been shown to improve visual acuity and contrast detection in people with early age-related macular degeneration.69 In laboratory studies, astaxanthin supplementation protects retinal cells against oxidative stress and significantly reduces the area of destructive new blood vessel growth on retinas, a hallmark of advanced macular degeneration.70,71
Studies of patients with age-related macular degeneration reveal significant improvements in retinal electrical outputs following supplementation with astaxanthin and other carotenoids.72
Glaucoma, an increase in the pressure of fluid inside the eyeball, eventually results in retinal cell death from oxidant damage and loss of blood flow. Astaxanthin restores retinal parameters to normal in eyes with experimentally-induced glaucoma.73
Astaxanthin, a red pigment that originates in marine algae, is one of nature’s most potent antioxidants. It has numerous other useful properties as well: it is an efficient blocker of ultraviolet radiation, it reduces the impact of glycation, and it decreases inflammatory responses.
Studies are revealing astaxanthin’s remarkable ability to fight the prime causes of aging, not only in the skin, where it was first studied, but in organs and tissues throughout the body. Astaxanthin protects and promotes healthy immune functioning, reduces cancer risks, mitigates the impact of diabesity, protects heart muscle and blood vessels, slows brain aging, and supports eye health.
These multiple benefits of astaxanthin, coupled with its proven safety record, make it a vital component of a responsible program of nutritional supplementation.
If you have any questions on the scientific content of this article, please call a Life Extension® Health Advisor at 1-866-864-3027.
- Hussein G, Sankawa U, Goto H, Matsumoto K, Watanabe H. Astaxanthin, a carotenoid with potential in human health and nutrition. J Nat Prod. 2006 Mar;69(3):443-9.
- Miyashita K. Function of marine carotenoids. Forum Nutr. 2009;61:136-46. doi: 10.1159/000212746. Epub 2009 Apr 7.
- Lemoine Y, Schoefs B. Secondary ketocarotenoid astaxanthin biosynthesis in algae: a multifunctional response to stress. Photosynth Res. 2010 Nov;106(1-2):155-77.
- Lyons NM, O’Brien NM. Modulatory effects of an algal extract containing astaxanthin on UVA-irradiated cells in culture. J Dermatol Sci. 2002 Oct;30(1):73-84.
- Hama S, Takahashi K, Inai Y, et al. Protective effects of topical application of a poorly soluble antioxidant astaxanthin liposomal formulation on ultraviolet-induced skin damage. J Pharm Sci. 2012 Aug;101(8):2909-16.
- Higuera-Ciapara I, Felix-Valenzuela L, Goycoolea FM. Astaxanthin: a review of its chemistry and applications. Crit Rev Food Sci Nutr. 2006;46(2):185-96.
- Yuan JP, Peng J, Yin K, Wang JH. Potential health-promoting effects of astaxanthin: a high-value carotenoid mostly from microalgae. Mol Nutr Food Res. 2011 Jan;55(1):150-65.
- Yazaki K, Yoshikoshi C, Oshiro S, Yanase S. Supplemental cellular protection by a carotenoid extends life span via Ins/IGF-1 signaling in Caenorhabditis elegans. Oxid Med Cell Longev. 2011;2011:596240.
- Kashima N, Fujikura Y, Komura T, et al. Development of a method for oral administration of hydrophobic substances to Caenorhabditis elegans: pro-longevity effects of oral supplementation with lipid-soluble antioxidants. Biogerontology. 2012 Jun;13(3):337-44.
- Available at: http://www.nhiondemand.com/viewcontent.aspx?mgid=1269. Accessed January 21, 2013.
- Terazawa S, Nakajima H, Shingo M, Niwano T, Imokawa G. Astaxanthin attenuates the UVB-induced secretion of prostaglandin E2 and interleukin-8 in human keratinocytes by interrupting MSK1 phosphorylation in a ROS depletion-independent manner. Exp Dermatol. 2012 Jul;21 Suppl 1:11-7.
- Yasui Y, Hosokawa M, Mikami N, Miyashita K, Tanaka T. Dietary astaxanthin inhibits colitis and colitis-associated colon carcinogenesis in mice via modulation of the inflammatory cytokines. Chem Biol Interact. 2011 Aug 15;193(1):79-87.
- Lee DH, Kim CS, Lee YJ. Astaxanthin protects against MPTP/MPP+-induced mitochondrial dysfunction and ROS production in vivo and in vitro. Food Chem Toxicol. 2011 Jan;49(1):271-80.
- Liu X, Osawa T. Astaxanthin protects neuronal cells against oxidative damage and is a potent candidate for brain food. Forum Nutr. 2009;61:129-35.
- Park JS, Mathison BD, Hayek MG, Zhang J, Reinhart GA, Chew BP. Astaxanthin modulates age-associated mitochondrial dysfunction in healthy dogs. J Anim Sci. 2012 Oct 16.
- Wolf AM, Asoh S, Hiranuma H, et al. Astaxanthin protects mitochondrial redox state and functional integrity against oxidative stress. J Nutr Biochem. 2010 May;21(5):381-9.
- Riccioni G, Speranza L, Pesce M, Cusenza S, D’Orazio N, Glade MJ. Novel phytonutrient contributors to antioxidant protection against cardiovascular disease. Nutrition. 2012 Jun;28(6):605-10.
- Sun Z, Liu J, Zeng X, et al. Protective actions of microalgae against endogenous and exogenous advanced glycation endproducts (AGEs) in human retinal pigment epithelial cells. Food Funct. 2011 May;2(5):251-8.
- Kidd P. Astaxanthin, cell membrane nutrient with diverse clinical benefits and anti-aging potential. Altern Med Rev. 2011 Dec;16(4):355-64.
- Anunciato TP, da Rocha Filho PA. Carotenoids and polyphenols in nutricosmetics, nutraceuticals, and cosmeceuticals. J Cosmet Dermatol. 2012 Mar;11(1):51-4.
- Martinez A, Rodriguez-Girones MA, Barbosa A, Costas M. Donator acceptor map for carotenoids, melatonin and vitamins. J Phys Chem A. 2008 Sep 25;112(38):9037-42.
- Petri D, Lundebye AK. Tissue distribution of astaxanthin in rats following exposure to graded levels in the feed. Comp Biochem Physiol C Toxicol Pharmacol. 2007 Mar;145(2):202-9.
- Tominaga K, Hongo N, Karato M, Yamashita E. Cosmetic benefits of astaxanthin on humans subjects. Acta Biochim Pol. 2012;59(1):43-7.
- Suganuma K, Nakajima H, Ohtsuki M, Imokawa G. Astaxanthin attenuates the UVA-induced up-regulation of matrix-metalloproteinase-1 and skin fibroblast elastase in human dermal fibroblasts. J Dermatol Sci. 2010 May;58(2):136-42.
- Camera E, Mastrofrancesco A, Fabbri C, et al. Astaxanthin, canthaxanthin and beta-carotene differently affect UVA-induced oxidative damage and expression of oxidative stress-responsive enzymes. Exp Dermatol. 2009 Mar;18(3):222-31.
- Chew BP, Park JS. Carotenoid action on the immune response. J Nutr. 2004 Jan;134(1):257S-61S.
- Nakao R, Nelson OL, Park JS, Mathison BD, Thompson PA, Chew BP. Effect of dietary astaxanthin at different stages of mammary tumor initiation in BALB/c mice. Anticancer Res. 2010 Jun;30(6):2171-5.
- Chew BP, Mathison BD, Hayek MG, Massimino S, Reinhart GA, Park JS. Dietary astaxanthin enhances immune response in dogs. Vet Immunol Immunopathol. 2011 Apr 15;140(3-4):199-206.
- Park JS, Mathison BD, Hayek MG, Massimino S, Reinhart GA, Chew BP. Astaxanthin stimulates cell-mediated and humoral immune responses in cats. Vet Immunol Immunopathol. 2011 Dec 15;144(3-4):455-61.
- Macedo RC, Bolin AP, Marin DP, Otton R. Astaxanthin addition improves human neutrophils function: in vitro study. Eur J Nutr. 2010 Dec;49(8):447-57.
- Bolin AP, Guerra BA, Nascimento SJ, Otton R. Changes in lymphocyte oxidant/antioxidant parameters after carbonyl and antioxidant exposure. Int Immunopharmacol. 2012 Dec;14(4): 690-7.
- Mahmoud FF, Haines DD, Abul HT, Abal AT, Onadeko BO, Wise JA. In vitro effects of astaxanthin combined with ginkgolide B on T lymphocyte activation in peripheral blood mononuclear cells from asthmatic subjects. J Pharmacol Sci. 2004 Feb;94(2):129-36.
- Mahmoud FF, Haines D, Al-Awadhi R, et al. In vitro suppression of lymphocyte activation in patients with seasonal allergic rhinitis and pollen-related asthma by cetirizine or azelastine in combination with ginkgolide B or astaxanthin. Acta Physiol Hung. 2012 Jun;99(2):173-84.
- Tanaka T, Shnimizu M, Moriwaki H. Cancer chemoprevention by carotenoids. Molecules. 2012;17(3):3202-42.
- Santocono M, Zurria M, Berrettini M, Fedeli D, Falcioni G. Lutein, zeaxanthin and astaxanthin protect against DNA damage in SK-N-SH human neuroblastoma cells induced by reactive nitrogen species. J Photochem Photobiol B. 2007 Jul 27;88(1):1-10.
- Nagendraprabhu P, Sudhandiran G. Astaxanthin inhibits tumor invasion by decreasing extracellular matrix production and induces apoptosis in experimental rat colon carcinogenesis by modulating the expressions of ERK-2, NFkB and COX-2. Invest New Drugs. 2011 Apr;29(2):207-24.
- Palozza P, Torelli C, Boninsegna A, et al. Growth-inhibitory effects of the astaxanthin-rich alga Haematococcus pluvialis in human colon cancer cells. Cancer Lett. 2009 Sep 28;283(1):108-17.
- Song XD, Zhang JJ, Wang MR, Liu WB, Gu XB, Lv CJ. Astaxanthin induces mitochondria-mediated apoptosis in rat hepatocellular carcinoma CBRH-7919 cells. Biol Pharm Bull. 2011;34(6): 839-44.
- Zhang X, Zhao WE, Hu L, Zhao L, Huang J. Carotenoids inhibit proliferation and regulate expression of peroxisome proliferators-activated receptor gamma (PPARgamma) in K562 cancer cells. Arch Biochem Biophys. 2011 Aug 1;512(1):96-106.
- Song X, Wang M, Zhang L, et al. Changes in cell ultrastructure and inhibition of JAK1/STAT3 signaling pathway in CBRH-7919 cells with astaxanthin. Toxicol Mech Methods. 2012 Nov;22(9): 679-86.
- Prabhu PN, Ashokkumar P, Sudhandiran G. Antioxidative and antiproliferative effects of astaxanthin during the initiation stages of 1,2-dimethyl hydrazine-induced experimental colon carcinogenesis. Fundam Clin Pharmacol. 2009 Apr;23(2):225-34.
- Uchiyama K, Naito Y, Hasegawa G, Nakamura N, Takahashi J, Yoshikawa T. Astaxanthin protects beta-cells against glucose toxicity in diabetic db/db mice. Redox Rep. 2002;7(5):290-3.
- Naito Y, Uchiyama K, Aoi W, et al. Prevention of diabetic nephropathy by treatment with astaxanthin in diabetic db/db mice. Biofactors. 2004;20(1):49-59.
- McCarty MF. Full-spectrum antioxidant therapy featuring astaxanthin coupled with lipoprivic strategies and salsalate for management of non-alcoholic fatty liver disease. Med Hypotheses. 2011 Oct;77(4):550-6.
- Arunkumar E, Bhuvaneswari S, Anuradha CV. An intervention study in obese mice with astaxanthin, a marine carotenoid--effects on insulin signaling and pro-inflammatory cytokines. Food Funct. 2012 Feb;3(2):120-6.
- Ikeuchi M, Koyama T, Takahashi J, Yazawa K. Effects of astaxanthin in obese mice fed a high-fat diet. Biosci Biotechnol Biochem. 2007 Apr;71(4):893-9.
- Choi HD, Kim JH, Chang MJ, Kyu-Youn Y, Shin WG. Effects of astaxanthin on oxidative stress in overweight and obese adults. Phytother Res. 2011 Dec;25(12):1813-8.
- Manabe E, Handa O, Naito Y, et al. Astaxanthin protects mesangial cells from hyperglycemia-induced oxidative signaling. J Cell Biochem. 2008 Apr 15;103(6):1925-37.
- Nakano M, Orimo N, Katagiri N, Tsubata M, Takahashi J, Van Chuyen N. Inhibitory effect of astraxanthin combined with Flavangenol on oxidative stress biomarkers in streptozotocin-induced diabetic rats. Int J Vitam Nutr Res. 2008 Jul-Sep;78(4-5):175-82.
- Sun Z, Liu J, Zeng X, et al. Protective actions of microalgae against endogenous and exogenous advanced glycation endproducts (AGEs) in human retinal pigment epithelial cells. Food Funct. 2011 May;2(5):251-8.
- Zhao ZW, Cai W, Lin YL, et al. Ameliorative effect of astaxanthin on endothelial dysfunction in streptozotocin-induced diabetes in male rats. Arzneimittelforschung. 2011;61(4):239-46.
- Hussein G, Nakamura M, Zhao Q, et al. Antihypertensive and neuroprotective effects of astaxanthin in experimental animals. Biol Pharm Bull. 2005 Jan;28(1):47-52.
- Sasaki Y, Kobara N, Higashino S, Giddings JC, Yamamoto J. Astaxanthin inhibits thrombosis in cerebral vessels of stroke-prone spontaneously hypertensive rats. Nutr Res. 2011 Oct;31(10):784-9.
- Hussein G, Goto H, Oda S, Sankawa U, Matsumoto K, Watanabe H. Antihypertensive potential and mechanism of action of astaxanthin: III. Antioxidant and histopathological effects in spontaneously hypertensive rats. Biol Pharm Bull. 2006 Apr;29(4):684-8.
- Yoshida H, Yanai H, Ito K, et al. Administration of natural astaxanthin increases serum HDL-cholesterol and adiponectin in subjects with mild hyperlipidemia. Atherosclerosis. 2010 Apr;209(2):520-3.
- Yang Y, Seo JM, Nguyen A, et al. Astaxanthin-rich extract from the green alga Haematococcus pluvialis lowers plasma lipid concentrations and enhances antioxidant defense in apolipoprotein E knockout mice. J Nutr. 2011 Sep;141(9):1611-7.
- Li W, Hellsten A, Jacobsson LS, Blomqvist HM, Olsson AG, Yuan XM. Alpha-tocopherol and astaxanthin decrease macrophage infiltration, apoptosis and vulnerability in atheroma of hyperlipidaemic rabbits. J Mol Cell Cardiol. 2004 Nov;37(5):969-78.
- Nakao R, Nelson OL, Park JS, Mathison BD, Thompson PA, Chew BP. Effect of astaxanthin supplementation on inflammation and cardiac function in BALB/c mice. Anticancer Res. 2010 Jul;30(7):2721-5.
- Ye Q, Huang B, Zhang X, Zhu Y, Chen X. Astaxanthin protects against MPP+-induced oxidative stress in PC12 cells via the HO-1/NOX2 axis. BMC Neurosci. 2012 Dec 29;13(1):156.
- Shen H, Kuo CC, Chou J, et al. Astaxanthin reduces ischemic brain injury in adult rats. FASEB J. 2009 Jun;23(6):1958-68.
- Lee DH, Lee YJ, Kwon KH. Neuroprotective effects of astaxanthin in oxygen-glucose deprivation in SH-SY5Y cells and global cerebral ischemia in rat. J Clin Biochem Nutr. 2010 Sep;47(2):121-9.
- Lu YP, Liu SY, Sun H, Wu XM, Li JJ, Zhu L. Neuroprotective effect of astaxanthin on H(2)O(2)-induced neurotoxicity in vitro and on focal cerebral ischemia in vivo. Brain Res. 2010 Nov 11;1360:40-8.
- Ikeda Y, Tsuji S, Satoh A, Ishikura M, Shirasawa T, Shimizu T. Protective effects of astaxanthin on 6-hydroxydopamine-induced apoptosis in human neuroblastoma SH-SY5Y cells. J Neurochem. 2008 Dec;107(6):1730-40.
- Chang CH, Chen CY, Chiou JY, Peng RY, Peng CH. Astaxanthine secured apoptotic death of PC12 cells induced by beta-amyloid peptide 25-35: its molecular action targets. J Med Food. 2010 Jun;13(3):548-56.
- Nakagawa K, Kiko T, Miyazawa T, Sookwong P, Tsuduki T, Satoh A. Amyloid beta-induced erythrocytic damage and its attenuation by carotenoids. FEBS Lett. 2011 Apr 20;585(8):1249-54.
- Kiko T, Nakagawa K, Satoh A, et al. Amyloid beta levels in human red blood cells. PLoS One. 2012;7(11):e49620.
- Satoh A, Tsuji S, Okada Y, et al. Preliminary clinical evaluation of toxicity and efficacy of a new astaxanthin-rich Haematococcus pluvialis extract. J Clin Biochem Nutr. 2009 May;44(3):280-4.
- Katagiri M, Satoh A, Tsuji S, Shirasawa T. Effects of astaxanthin-rich Haematococcus pluvialis extract on cognitive function: a randomised, double-blind, placebo-controlled study. J Clin Biochem Nutr. 2012 Sep;51(2):102-7.
- Piermarocchi S, Saviano S, Parisi V, et al. Carotenoids in Age-Related Maculopathy Italian Study (CARMIS): two-year results of a randomized study. Eur J Ophthalmol. 2012 Mar-Apr;22(2):216-25.
- Izumi-Nagai K, Nagai N, Ohgami K, et al. Inhibition of choroidal neovascularization with an anti-inflammatory carotenoid astaxanthin. Invest Ophthalmol Vis Sci. 2008 Apr;49(4):1679-85.
- Nakajima Y, Inokuchi Y, Shimazawa M, Otsubo K, Ishibashi T, Hara H. Astaxanthin, a dietary carotenoid, protects retinal cells against oxidative stress in-vitro and in mice in-vivo. J Pharm Pharmacol. 2008 Oct;60(10):1365-74.
- Parisi V, Tedeschi M, Gallinaro G, Varano M, Saviano S, Piermarocchi S. Carotenoids and antioxidants in age-related maculopathy italian study: multifocal electroretinogram modifications after 1 year. Ophthalmology. 2008 Feb;115(2):324-33 e2.
- Cort A, Ozturk N, Akpinar D, et al. Suppressive effect of astaxanthin on retinal injury induced by elevated intraocular pressure. Regul Toxicol Pharmacol. 2010 Oct;58(1):121-30.
- Shanmugam S, Park JH, Kim KS, et al. Enhanced bioavailability and retinal accumulation of lutein from self-emulsifying phospholipid suspension (SEPS). Int J Pharm. 2011 Jun 30;412(1-2): 99-105.
- Kovács T, Varga G, Erces D, et al. Dietary phosphatidylcholine supplementation attenuates inflammatory mucosal damage in a rat model of experimental colitis. Shock. 2012 Aug;38(2):177-85.
- Tokes T, Eros G, Bebes A, et al. Protective effects of a phosphatidylcholine-enriched diet in lipopolysaccharide-induced experimental neuroinflammation in the rat. Shock. 2011 Nov;36(5): 458-65.
- Yang HJ, Sugiura Y, Ikegami K, Konishi Y, Setou M. Axonal gradient of arachidonic acid-containing phosphatidylcholine and its dependence on actin dynamics. J Biol Chem. 2012 Feb 17;287(8):5290-300.
- Rengel D, Diez-Navajas A, Serna-Rico A, Veiga P, Muga A, Milicua JC. Exogenously incorporated ketocarotenoids in large unilamellar vesicles. Protective activity against peroxidation. Biochim Biophys Acta. 2000 Jan 15;1463(1):179-87.
- Goto S, Kogure K, Abe K, et al. Efficient radical trapping at the surface and inside the phospholipid membrane is responsible for highly potent antiperoxidative activity of the carotenoid astaxanthin. Biochim Biophys Acta. 2001 Jun 6;1512(2):251-8.
- Shibata A, Kiba Y, Akati N, Fukuzawa K, Terada H. Molecular characteristics of astaxanthin and beta-carotene in the phospholipid monolayer and their distributions in the phospholipid bilayer. Chem Phys Lipids. 2001 Nov;113(1-2):11-22.